LENSAR, Inc. (LNSR) 8-K Current Report: March 12, 2026
Filed: March 12, 2026
Health Care
Surgical & Medical Instruments & ApparatusLENSAR, Inc. (LNSR) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 8.01: Other Events
LENSAR, Inc. 8-K Mar 12, 2026 Event Analysis
Item 8.01 · Other Events
- • LENSAR secured revolving margin credit facility with Wells Fargo, up to $50M, backed by brokerage account collateral
- • Only ~$10M in collateral deposited to date, limiting immediate borrowing capacity well below the $50M ceiling
- • Interest rate at company's election: fixed (Treasury Yield + margin) or variable (SOFR + margin) — no rate disclosed
- • Facility is non-purpose, meaning proceeds can be deployed flexibly across operations, M&A, or strategic uses
- • Default triggers include margin calls for additional collateral, signaling borrowing capacity tied directly to collateral account value fluctuations
Other LENSAR, Inc. 8-K Filings
Get deeper insights on LENSAR, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.